Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PSEC

Prospect Capital Corp

Feb 13 • 10:54AM ET

3.01

+0.12 3.98 %

Financial • Asset Management • USA • NASD

Peers: ARCC MAIN TCPC HTGC GSBD TSLX TPVG NMFC CGBD SLRC

| Held by: BIZD HIPS VPC PEX PCR LBO ORR

Index	-	P/E	-	EPS (ttm)	-0.82	Insider Own	18.95%	Shs Outstand	476.46M	Perf Week	13.83%
Market Cap	1.45B	Forward P/E	7.15	EPS next Y	0.42	Insider Trans	4.26%	Shs Float	391.06M	Perf Month	1.86%
Enterprise Value	4.88B	PEG	-	EPS next Q	0.11	Inst Own	17.77%	Short Float	9.32%	Perf Quarter	6.94%
Income	-356.19M	P/S	9.27	EPS this Y	-38.96%	Inst Trans	-	Short Ratio	8.80	Perf Half Y	5.44%
Sales	156.37M	P/B	0.48	EPS next Y	-10.64%	ROA	-3.40%	Short Interest	36.46M	Perf YTD	16.02%
Book/sh	6.21	P/C	38.09	EPS next 5Y	-19.61%	ROE	-4.85%	52W High	4.47 -32.77%	Perf Year	-31.08%
Cash/sh	0.08	P/FCF	6.44	EPS past 3/5Y	- -98.19%	ROIC	-5.56%	52W Low	2.45 22.65%	Perf 3Y	-60.67%
Dividend Est.	0.51 (16.97%)	EV/EBITDA	-	Sales past 3/5Y	-33.98% -20.09%	Gross Margin	-5.75%	Volatility	4.64% 3.56%	Perf 5Y	-58.61%
Dividend TTM	0.54 (17.97%)	EV/Sales	31.23	EPS Y/Y TTM	-291.60%	Oper. Margin	-64.23%	ATR (14)	0.10	Perf 10Y	-51.30%
Dividend Ex-Date	Feb 25, 2026	Quick Ratio	0.57	Sales Y/Y TTM	-64.39%	Profit Margin	-227.79%	RSI (14)	64.61	Recom	5.00
Dividend Gr. 3/5Y	-5.90% -3.58%	Current Ratio	0.57	EPS Q/Q	80.42%	SMA20	7.45%	Beta	0.84	Target Price	2.50
Payout	-	Debt/Eq	0.40	Sales Q/Q	-75.05%	SMA50	11.20%	Rel Volume	2.42	Prev Close	2.89
Employees	-	LT Debt/Eq	0.40	Earnings	Feb 09 AMC	SMA200	2.16%	Avg Volume	4.14M	Price	3.01
IPO	Jul 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	82.34% 12.58%	Trades		Volume	2,552,118	Change	3.98%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-21	Upgrade	Raymond James	Underperform → Mkt Perform
Jun-25-20	Initiated	Wells Fargo	Underweight	$4.50
Apr-20-20	Downgrade	Raymond James	Mkt Perform → Underperform
Jan-22-19	Downgrade	Barclays	Equal Weight → Underweight	$7 → $6
Aug-30-17	Upgrade	Raymond James	Underperform → Mkt Perform
May-11-17	Downgrade	FBR & Co.	Outperform → Mkt Perform	$9.50 → $8.50
Aug-31-16	Reiterated	FBR Capital	Outperform	$9 → $10
Feb-11-16	Reiterated	RBC Capital Mkts	Sector Perform	$10 → $9
Jan-11-16	Downgrade	Wells Fargo	Market Perform → Underperform
Jul-01-15	Initiated	Cantor Fitzgerald	Hold
Dec-18-14	Downgrade	Barclays	Overweight → Equal Weight	$12 → $11
Dec-08-14	Reiterated	MLV & Co	Buy	$11 → $10.75
Feb-04-14	Upgrade	Wunderlich	Hold → Buy	$12
Jan-22-14	Initiated	MLV & Co	Buy	$12
Jan-21-14	Initiated	MLV & Co	Buy	$12
Dec-05-13	Initiated	Wunderlich	Hold	$12
Jan-04-13	Initiated	Barclays	Overweight	$12
Nov-12-12	Upgrade	Stifel Nicolaus	Sell → Hold
Dec-02-10	Initiated	UBS	Neutral	$9.50
Dec-21-09	Downgrade	DA Davidson	Buy → Neutral	$11.75

Show Previous Ratings

Feb-10-26 05:20PM	Prospect Capital Q2 Earnings Call Highlights (MarketBeat) +10.34%
04:01PM	Prospect Capital Corp (PSEC) Q2 2026 Earnings Call Highlights: Strong Investment Income and ... (GuruFocus.com)
08:30AM	Prospect Capital Corporation Q2 2026 Earnings Call Summary (Moby)
Feb-09-26 04:26PM	Prospect Capital: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:08PM	Prospect Capital Announces Financial Results for December 2025 (GlobeNewswire)
09:00AM	Loading…
Feb-06-26 09:00AM	Prospect Capital Schedules Second Fiscal Quarter Earnings Release and Conference Call (GlobeNewswire)
Feb-02-26 05:02AM	Wall Street Warns About a Possible Private Credit Collapse. Should Investors Worry About These Ultra-High-Yield Stocks? (Motley Fool)
Jan-08-26 04:57PM	Prospect Capital Announces Annual Meeting Update (GlobeNewswire)
Dec-16-25 04:01PM	Prospect Capital Announces Annual Meeting Update (GlobeNewswire)
Nov-18-25 01:04PM	Want $3,500 per Year in Monthly Passive Income? Invest Just $2,500 in These Dividend Stocks (24/7 Wall St.)
Nov-08-25 02:06AM	Prospect Capital Corp (PSEC) Q1 2026 Earnings Call Highlights: Strong Income Generation and ... (GuruFocus.com)
Nov-06-25 07:14PM	Prospect Capital: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +7.45%
04:14PM	Prospect Capital Announces Financial Results for September 2025 (GlobeNewswire)
Nov-05-25 07:00AM	Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call (GlobeNewswire)
Oct-28-25 07:00AM	Prospect Capital Corporation Announces Pricing of $167 Million 5.5% Oversubscribed Institutional Unsecured Notes Offering (GlobeNewswire)
01:14AM	Loading…
Oct-07-25 01:14AM	Why Prospect Capital Corporation (PSEC) Stands Out as a Promising BDC Dividend Stock in 2025 (Insider Monkey)
Sep-30-25 12:50PM	Prospect Capital (PSEC) Stock Is Up, What You Need To Know (StockStory)
Sep-25-25 12:41PM	Why Is Prospect Capital (PSEC) Stock Soaring Today (StockStory)
Sep-15-25 08:17AM	Prospect Capital And Thesis Capital Partners Invests $18 Million in The Ridge (Insider Monkey)
Sep-08-25 07:01AM	Prospect Capital Corporation and Affiliate Complete $18 Million Investment in The Ridge (GlobeNewswire)
Sep-02-25 01:30AM	The 5 Most Interesting Analyst Questions From Prospect Capital's Q2 Earnings Call (StockStory)
Aug-28-25 03:05AM	Prospect Capital Corp (PSEC) Q4 2025 Earnings Call Highlights: Strategic Shift to Middle Market ... (GuruFocus.com)
Aug-26-25 05:32PM	Prospect Capital (NASDAQ:PSEC) Posts Q2 Sales In Line With Estimates (StockStory)
05:17PM	Prospect Capital: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:52PM	Prospect Capital Announces Financial Results for June 2025 (GlobeNewswire)
Aug-22-25 03:32PM	Prospect Capital Schedules Fiscal Year Earnings Release and Conference Call (GlobeNewswire)
Aug-21-25 12:21AM	Prospect Capital (PSEC) Acquires QC Holdings, Here's How the Market Reacted (Insider Monkey)
Jul-29-25 01:45AM	How Prospect Capital (PSEC) Maintains One of the Highest Dividend Rates (Insider Monkey)
Jul-01-25 07:00AM	Prospect Capital Corporation Acquires QC Holdings, Inc. (GlobeNewswire)
Jun-13-25 04:01PM	Priority Income Fund Announces Redemption of its 6.125% Series I Term Preferred Stock Due 2028 (GlobeNewswire)
01:08PM	Loading…
Jun-11-25 01:08PM	Priority Income Fund Announces 17.4% Annualized Total Cash Distribution Rate (on Class R Offering Price) with Bonus and Base Common Shareholder Distributions for June 2025 through August 2025 (GlobeNewswire)
Jun-09-25 04:01PM	Prospect Capital Announces Special Meeting Update (GlobeNewswire)
Jun-03-25 08:45AM	Private Debt Investor Features Grier Eliasek in June Edition of Middle Market Direct Lending Report (GlobeNewswire)
May-19-25 12:00PM	Prospect Capital Corporation Announces Redemption of its 3.706% Notes due 2026 (GlobeNewswire)
May-12-25 04:01PM	Priority Income Fund Announces Redemption of its 6.625% Series F Term Preferred Stock Due 2027 (GlobeNewswire)
May-10-25 03:05AM	Prospect Capital Corp (PSEC) Q3 2025 Earnings Call Highlights: Strong Net Investment Income ... (GuruFocus.com)
May-09-25 09:17AM	Prospect Capital Honored for 2025 Middle-Market Deals of the Year Awards for Druid City Independent Sponsor Investment in Healthcare Industry (GlobeNewswire)
May-08-25 04:42PM	Prospect Capital: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Prospect Capital Announces Financial Results for Fiscal March 2025 Quarter (GlobeNewswire)
May-06-25 04:10PM	Prospect Capital Schedules Third Fiscal Quarter Earnings Release and Conference Call (GlobeNewswire)
May-02-25 11:44PM	BDC Weekly Review: BDCs Are Taking Advantage Of Wider Spreads (Seeking Alpha)
Apr-30-25 04:12PM	Prospect Capital Corporation (PSEC): Among the Cheap Dividend Stocks Being Targeted by Short Sellers (Insider Monkey)
Apr-23-25 12:26PM	Fidus Investment: Irresistible Buying Opportunity (Seeking Alpha)
Apr-18-25 08:30AM	Prospect Capital Corporation Announces Results of Cash Tender Offer For Any and All of its Outstanding 3.706% Notes due 2026 (GlobeNewswire)
Apr-17-25 09:15AM	Two BDCs For 60 Cents On The Dollar: 1 To Buy And 1 To Avoid (Seeking Alpha)
Apr-16-25 10:35AM	FS KKR Capital: Buy The Tariff Tantrum, Secure A 13.7% Yield (Seeking Alpha)
Apr-13-25 09:48AM	New Mountain Finance: A 14% Yield That Is Worth Picking Up (Rating Upgrade) (Seeking Alpha)
Apr-11-25 08:30AM	QC Holdings, Inc. to be Acquired by Prospect Capital Corporation (GlobeNewswire)
Apr-09-25 08:33AM	Prospect Capital Corporation Announces Launch of Cash Tender Offer For Any and All of its Outstanding 3.706% Notes due 2026 (GlobeNewswire) +6.29%
07:00AM	Prospect Capital Corporation Hosting Upcoming Webinar: Medium Term Notes Senior Position and Attractive Income (GlobeNewswire)
Apr-03-25 07:01AM	Prospect Capital's Credit Ratings Reaffirmed Investment Grade by Egan-Jones Ratings Company (GlobeNewswire)
Mar-30-25 03:37AM	BDC Weekly Review: PSEC Gets More Bad Press (Seeking Alpha)
Mar-28-25 07:01AM	Prospect Capital's Credit Ratings Reaffirmed Investment Grade by Morningstar DBRS with Stable Trend (GlobeNewswire)
Mar-26-25 03:08PM	Golub Capital BDC's NAV, Valuation And Dividend Vs. 11 BDC Peers - Part 2 (Includes Updated Dividend Projections) (SeekingAlpha)
Mar-25-25 10:43AM	Prospect Capital Corporation (PSEC): Among Stocks Receiving the Most Insider Love in March (InsiderMonkey)
07:01AM	Prospect Capital Repays March 2025 Bond and Achieves Track Record of $4.7 Billion in Cumulative Principal Bond Repayments During More Than 20 Year History (GlobeNewswire)
Mar-20-25 11:15AM	Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers (SeekingAlpha)
01:31AM	Goldman Sachs BDC: Dividend Alignment, But Still A Buy (SeekingAlpha)
Mar-19-25 07:01AM	R-V Industries to Participate in Several Upcoming Industry Events (GlobeNewswire)
Mar-13-25 04:30PM	Priority Income Fund Announces 13.0% Annualized Total Cash Distribution Rate (on Class R Offering Price) with Bonus and Base Common Shareholder Distributions for March 2025 through May 2025 (GlobeNewswire)
07:01AM	Town & Country Living Unveils Stylish and Functional Pet Comfort Collection at Global Pet Expo 2025 (GlobeNewswire)
Mar-12-25 09:30AM	Town & Country Living Partners with Draper James to Launch Charming Cross-Category Home Collection (GlobeNewswire)
Mar-11-25 03:09PM	Priority Income Fund Announces Declaration of Preferred Stock Distributions for March 2025 (GlobeNewswire)
Mar-10-25 07:04PM	Prospect Capital Corporation Releases Updated Prospect Highlights (GlobeNewswire)
06:09PM	Mity Inc. Announces Successful Launch of Traversa Non-Emergency Medical Transport Chair (GlobeNewswire)
05:51PM	Valley Electric Received Three Separate Awards for Excellence in Engineering, Design and Sustainability (GlobeNewswire)
05:50PM	Druid City Vital Care Recognized at Vital Care Infusion Services Annual Conference (GlobeNewswire)
05:49PM	Tower Loan Announces New Customer Mobile App (GlobeNewswire)
05:31PM	Prospect Capital Achieves Outstanding Corporate Culture Recognition Based on Independent Culture Amp Survey (GlobeNewswire)
05:29PM	Prospect Capital and Refuel Agency Create a Positive Impact for Military Veterans Through Philanthropic Partnership (GlobeNewswire)
01:15PM	Priority Income Fund Announces Redemption of its 6.000% Series H Term Preferred Stock Due 2026 (GlobeNewswire)
Mar-08-25 06:50AM	Prospect Capital Corporation (PSEC): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? (Insider Monkey)
Feb-12-25 02:08AM	Prospect Capital Corp (PSEC) Q2 2025 Earnings Call Highlights: Strong Liquidity and Secured ... (GuruFocus.com)
12:04AM	Q2 2025 Prospect Capital Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-10-25 04:09PM	Prospect Capital: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Prospect Capital Announces Financial Results for Fiscal December 2024 Quarter (GlobeNewswire)
Feb-03-25 05:00PM	Prospect Capital Schedules Second Fiscal Quarter Earnings Release and Conference Call (GlobeNewswire)
Jan-31-25 07:01AM	Prospect Capital Corporation Makes $65 Million Investment in Taos Footwear (GlobeNewswire)
Dec-19-24 05:14PM	NewStar Exchange Acquires Newly Constructed Built-to-Rent ('BTR') Community in Charlotte, North Carolina and Launches New 1031 Delaware Statutory Trust Offering (PR Newswire)
Dec-17-24 09:13AM	Prospects Private Credit Fund Gets Second Downgrade to Junk (Bloomberg)
Dec-13-24 08:30PM	KBW Announces Index Rebalancing for Fourth-Quarter 2024 (GlobeNewswire)
Dec-09-24 02:46PM	Prospect Capital Corporation Hosting Upcoming Webinar: Preferred Stock as a Low Volatility, Downside Protected, and Income Generating Asset Class (GlobeNewswire)
Dec-06-24 07:04PM	Prospect Capitals Private Credit Fund Cut to Junk by S&P (Bloomberg)
Nov-25-24 07:01AM	National Property REIT Corp. Exits Arlington Park Investment with 2.4 Times Cash on Cash Return (GlobeNewswire)
Nov-22-24 05:17PM	Priority Income Fund Announces Redemption of its 6.250% Series G Term Preferred Stock Due 2026 (GlobeNewswire)
Nov-21-24 07:01AM	National Property REIT Corp. Exits Dylan at Grayson Investment with 1.7 Times Cash on Cash Return (GlobeNewswire)
Nov-12-24 07:01AM	Prospect Capital Corporation to Present at the 2024 Markets Group NYC Private Credit Conference (GlobeNewswire)
Nov-09-24 02:07AM	Prospect Capital Corp (PSEC) Q1 2025 Earnings Call Highlights: Strong Investment Income and ... (GuruFocus.com)
Nov-08-24 01:24PM	Prospect Capital Plunges on First Dividend Cut Since 2017 (Bloomberg) -14.53%
07:10AM	Prospect Capital: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:01AM	Prospect Capital Announces Financial Results for Fiscal September 2024 Quarter (GlobeNewswire)
Nov-07-24 02:18PM	Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call (GlobeNewswire)
Oct-21-24 07:00AM	Prospect Capital Corporation Upsizes Preferred Stock Offering to $2.25 Billion (GlobeNewswire)
Oct-18-24 09:50AM	Prospect Capital Corporation Provides First Lien Senior Secured Term and Convertible Loans to Support the Acquisition of Druid City Infusion by Inlet Road Capital Management (GlobeNewswire)
Oct-15-24 11:31AM	Prospect Capital Corporation Closes $764 Million of New Investments in Fiscal Year June 2024 (GlobeNewswire)
Oct-14-24 01:42PM	Nails Inc. Eyes North America With Sale to Pacific World Corp. (WWD)
Oct-07-24 10:28AM	Prospect Capital Corporation Extends and Increases Revolving Credit Facility to Over $2.1 Billion of Aggregate Commitments (GlobeNewswire)
Oct-03-24 07:00AM	Prospect Capital Celebrates its 20th Anniversary as a Leading Provider of Private Debt and Equity to U.S. Middle-Market Companies with Over $20 Billion Invested and More than 300 Portfolio Company Exits (GlobeNewswire)
Sep-24-24 05:39PM	Prospects Private Debt Fund on Cusp of Junk After Outlook Cuts (Bloomberg)
Sep-18-24 06:24PM	S&P Puts $8 Billion Prospect Fund on Negative Outlook (Bloomberg)

Prospect Capital Corp., a traded business development company invests in middle market companies located in the United States. The fund targets companies operating across a broad range of sectors. It provides debt and equity financing for buyout, growth, development, and recapitalization. It acts as a co-investor and takes controlling interest. The company was founded on April 13, 2004 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Eliasek M Grier	Chief Operating Officer	Feb 11 '26	Buy	2.92	942,800	2,749,770	3,443,930	Feb 13 07:00 AM
Eliasek M Grier	Chief Operating Officer	Sep 25 '25	Buy	2.71	370,000	1,002,700	2,501,130	Sep 29 04:01 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Sep 25 '25	Buy	2.72	925,000	2,517,758	86,067,158	Sep 29 04:00 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Sep 24 '25	Buy	2.62	741,158	1,939,610	85,142,158	Sep 26 04:02 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Sep 23 '25	Buy	2.66	384,000	1,021,478	84,401,000	Sep 25 04:02 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Sep 22 '25	Buy	2.66	374,500	997,219	84,017,000	Sep 24 04:02 PM
Stark Eugene S	Director	Sep 17 '25	Buy	2.79	2,500	6,975	60,000	Sep 19 03:29 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Jun 23 '25	Buy	3.16	319,000	1,008,646	83,585,026	Jun 25 04:15 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Jun 20 '25	Buy	3.19	623,300	1,988,763	83,266,026	Jun 24 04:46 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 24 '25	Buy	4.24	24,000	101,681	82,594,540	Mar 26 04:00 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 21 '25	Buy	4.26	24,000	102,250	82,570,540	Mar 25 04:06 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 20 '25	Buy	4.28	24,000	102,667	82,546,540	Mar 24 04:02 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 19 '25	Buy	4.30	24,000	103,130	82,509,933	Mar 21 04:08 PM
Gremp William	Director	Mar 18 '25	Buy	4.29	19,100	81,984	75,153	Mar 20 04:01 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 18 '25	Buy	4.30	24,000	103,222	82,485,933	Mar 20 04:01 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 17 '25	Buy	4.30	240,000	1,033,104	82,461,933	Mar 19 04:01 PM
Gremp William	Director	Mar 14 '25	Buy	4.24	900	3,816	56,053	Mar 18 05:29 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 14 '25	Buy	4.28	240,000	1,026,600	82,221,933	Mar 18 04:05 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 13 '25	Buy	4.20	240,000	1,009,104	81,981,933	Mar 17 04:01 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 12 '25	Buy	4.25	240,000	1,018,920	81,741,933	Mar 14 04:01 PM
Barry John F	CHIEF EXECUTIVE OFFICER	Mar 11 '25	Buy	4.32	2,000,000	8,640,000	81,501,933	Mar 13 04:01 PM

Open in Screener

LUCK

Lucky Strike Entertainment Corp

Feb 13 • 10:54AM ET

7.80

+0.26 3.38 %

Consumer Cyclical • Leisure • USA • NYSE

LUCK Lucky Strike Entertainment Corp daily Stock Chart

Held by: VTI VB VXF VBK CBSE VCR SCHA ITOT DFAS DFAC

Index	-	P/E	-	EPS (ttm)	-0.68	Insider Own	44.83%	Shs Outstand	78.96M	Perf Week	17.57%
Market Cap	1.07B	Forward P/E	33.57	EPS next Y	0.23	Insider Trans	0.15%	Shs Float	75.97M	Perf Month	-15.18%
Enterprise Value	4.36B	PEG	-	EPS next Q	0.16	Inst Own	53.84%	Short Float	3.18%	Perf Quarter	-7.09%
Income	-94.29M	P/S	0.87	EPS this Y	90.60%	Inst Trans	-2.35%	Short Ratio	7.80	Perf Half Y	-21.02%
Sales	1.24B	P/B	-	EPS next Y	2000.03%	ROA	-2.70%	Short Interest	2.41M	Perf YTD	-7.97%
Book/sh	-2.65	P/C	11.19	EPS next 5Y	-	ROE	-	52W High	13.25 -41.17%	Perf Year	-39.05%
Cash/sh	0.70	P/FCF	25.04	EPS past 3/5Y	19.62% -322.04%	ROIC	-3.17%	52W Low	5.70 36.63%	Perf 3Y	-44.40%
Dividend Est.	0.24 (3.08%)	EV/EBITDA	14.92	Sales past 3/5Y	9.63% -	Gross Margin	23.87%	Volatility	9.01% 6.60%	Perf 5Y	-
Dividend TTM	0.22 (2.89%)	EV/Sales	3.52	EPS Y/Y TTM	-48435.71%	Oper. Margin	11.94%	ATR (14)	0.52	Perf 10Y	-
Dividend Ex-Date	Feb 20, 2026	Quick Ratio	0.63	Sales Y/Y TTM	4.94%	Profit Margin	-7.60%	RSI (14)	47.19	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	0.69	EPS Q/Q	-168.69%	SMA20	-2.30%	Beta	0.71	Target Price	11.55
Payout	-	Debt/Eq	-	Sales Q/Q	2.26%	SMA50	-8.37%	Rel Volume	0.69	Prev Close	7.54
Employees	12565	LT Debt/Eq	-	Earnings	Feb 04 AMC	SMA200	-14.77%	Avg Volume	309.39K	Price	7.80
IPO	Apr 23, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1335.96% -1.83%	Trades		Volume	54,746	Change	3.38%

Date	Action	Analyst	Rating Change	Price Target Change
May-12-25	Downgrade	Roth Capital	Buy → Neutral	$9
Jan-17-25	Downgrade	JP Morgan	Overweight → Neutral	$15 → $12

Feb-11-26 12:39AM	5 Must-Read Analyst Questions From Lucky Strike's Q4 Earnings Call (StockStory)
Feb-05-26 11:55AM	Why Lucky Strike (LUCK) Shares Are Trading Lower Today (StockStory) -13.51%
12:31AM	LUCK Q4 Deep Dive: Flat Same-Store Sales, Margin Pressure, and Brand Consolidation Shape Outlook (StockStory)
12:07AM	Bowlero Q2 Earnings Call Highlights (MarketBeat)
12:00AM	Lucky Strike Entertainment Corp (LUCK) Q2 2026 Earnings Call Highlights: Strategic Acquisitions ... (GuruFocus.com)
08:29PM	Loading…
Feb-04-26 08:29PM	Lucky Strike (LUCK) Earnings Call Transcript (Motley Fool)
07:00PM	Lucky Strike Entertainment (LUCK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:15PM	Lucky Strike Entertainment Reports Second Quarter Results for Fiscal Year 2026 (Business Wire)
Feb-03-26 05:30PM	Lucky Strike Entertainment Declares Common Stock Dividend (Business Wire) -9.18%
07:24AM	Lucky Strike Entertainment Corp (LUCK) Q2 2026 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-02-26 10:33PM	Reflecting On Leisure Facilities Stocks' Q3 Earnings: Lucky Strike (NYSE:LUCK) (StockStory)
10:01PM	Lucky Strike (LUCK) Q4 Earnings Report Preview: What To Look For (StockStory)
Jan-30-26 09:40AM	Are Investors Undervaluing Lucky Strike Entertainment (LUCK) Right Now? (Zacks)
Jan-28-26 08:30AM	Lucky Strike Entertainment and Professional Bowlers Association Appoint Peter Murray as CEO of PBA and Head of Media for Lucky Strike Entertainment (Business Wire) -5.55%
Jan-27-26 04:15PM	Lucky Strike Entertainment to Report Second Quarter 2026 Financial Results on February 4, 2026 (Business Wire)
11:03PM	Loading…
Jan-25-26 11:03PM	3 Reasons to Sell LUCK and 1 Stock to Buy Instead (StockStory)
Jan-06-26 03:46PM	Why Is Lucky Strike (LUCK) Stock Soaring Today (StockStory) +7.37%
Dec-04-25 04:28PM	Lucky Strike Entertainment Opens New Aliso Viejo Location (Business Wire)
Nov-25-25 01:34PM	3 High-Flying Stocks That Concern Us (StockStory)
Nov-24-25 04:56PM	Lucky Strike, Ralph Lauren, Under Armour, and YETI Shares Skyrocket, What You Need To Know (StockStory)
Nov-11-25 12:26PM	Why Lucky Strike (LUCK) Stock Is Up Today (StockStory)
12:33AM	5 Insightful Analyst Questions From Lucky Strike's Q3 Earnings Call (StockStory)
Nov-05-25 08:35AM	LUCK Q3 Deep Dive: Event Recovery, F&B Growth, and Strategic Acquisitions Shape Outlook (StockStory)
12:12AM	Lucky Strike Entertainment Corp (LUCK) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Nov-04-25 07:00PM	Lucky Strike Entertainment (LUCK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:00PM	Lucky Strike Entertainment (LUCK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:27PM	Lucky Strike (NYSE:LUCK) Posts Better-Than-Expected Sales In Q3 (StockStory)
04:05PM	Lucky Strike Entertainment Reports First Quarter Results for Fiscal Year 2026 and Increases Common Stock Dividend (Business Wire)
Nov-03-25 07:44AM	Lucky Strike Entertainment Corp (LUCK) Q1 2026 Earnings Report Preview: What to Look For (GuruFocus.com)
Nov-02-25 10:08PM	Earnings To Watch: Lucky Strike (LUCK) Reports Q3 Results Tomorrow (StockStory)
09:40AM	Loading…
Oct-29-25 09:40AM	Is Lucky Strike Entertainment (LUCK) Stock Undervalued Right Now? (Zacks)
Oct-23-25 04:15PM	Lucky Strike Entertainment to Report First Quarter 2026 Financial Results on November 4, 2025 (Business Wire)
Oct-22-25 12:05AM	3 Reasons to Avoid LUCK and 1 Stock to Buy Instead (StockStory) -5.50%
Oct-20-25 09:10AM	VICI Properties Reloads Agreement for Northfield Park With Clairvest (Zacks)
Oct-17-25 12:40AM	3 Small-Cap Stocks That Concern Us (StockStory) -6.65%
Oct-13-25 04:41PM	Lucky Strike (LUCK) Stock Trades Up, Here Is Why (StockStory)
Oct-10-25 12:41AM	3 Volatile Stocks We Think Twice About (StockStory)
Oct-07-25 03:05PM	Why Lucky Strike (LUCK) Stock Is Trading Lower Today (StockStory)
Sep-29-25 11:35PM	Spotting Winners: Lucky Strike (NYSE:LUCK) And Leisure Facilities Stocks In Q2 (StockStory)
Sep-16-25 10:28PM	Lucky Strike Entertainment Corporation Announces Pricing of Proposed Senior Secured Notes Offering and Refinancing (Business Wire)
Sep-15-25 11:30AM	Lucky Strike offers aid to Pinstripes customers, workers (Nation's Restaurant News)
Sep-10-25 03:10PM	Why Lucky Strike (LUCK) Shares Are Trading Lower Today (StockStory)
Sep-04-25 01:31AM	5 Must-Read Analyst Questions From Lucky Strike's Q2 Earnings Call (StockStory)
Aug-29-25 01:30AM	LUCK Q2 Deep Dive: Margin Recovery and Mixed Traffic Trends Amid Expansion Push (StockStory)
Aug-28-25 02:43PM	Why Lucky Strike (LUCK) Stock Is Nosediving (StockStory)
10:05AM	Lucky Strike Entertainment (LUCK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:55AM	Lucky Strike's (NYSE:LUCK) Q2: Beats On Revenue, Guides for Strong Full-Year Sales (StockStory)
07:30AM	Lucky Strike Entertainment Reports Fourth Quarter and Full Year Results for Fiscal Year 2025 (Business Wire)
Aug-27-25 07:25PM	Trip.com (TCOM) Q2 Earnings and Revenues Beat Estimates (Zacks)
Aug-26-25 11:02PM	What To Expect From Lucky Strike's (LUCK) Q2 Earnings (StockStory)
Aug-21-25 04:15PM	Lucky Strike Entertainment to Report Fourth Quarter and Full Year 2025 Financial Results on August 28, 2025 (Business Wire) +5.25%
Aug-19-25 05:00PM	Lucky Strike Entertainment Declares Common Stock Dividend (Business Wire)
08:15AM	Viking Holdings (VIK) Q2 Earnings Match Estimates (Zacks)
Aug-18-25 12:44AM	3 Profitable Stocks We Keep Off Our Radar (StockStory)
Aug-14-25 08:18AM	Arista Networks and Lucky Strike Entertainment have been highlighted as Zacks Bull and Bear of the Day (Zacks)
06:30AM	Bear of the Day: Lucky Strike Entertainment (LUCK) (Zacks)
Aug-13-25 05:18AM	New Strong Sell Stocks for August 13th (Zacks)
Aug-12-25 03:00PM	Madison Square Garden (MSGS) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
Aug-11-25 07:55AM	AMC Entertainment (AMC) Reports Break-Even Earnings for Q2 (Zacks)
Aug-08-25 12:34AM	1 of Wall Street's Favorite Stock to Target This Week and 2 We Find Risky (StockStory)
Aug-07-25 07:20PM	Skillz Inc. (SKLZ) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-31-25 08:00AM	Lucky Strike Entertainment Continues Portfolio Expansion with Acquisition of Two Iconic Water Parks and Three Landmark Family Entertainment Centers (Business Wire)
Jul-29-25 12:01AM	3 Reasons to Avoid LUCK and 1 Stock to Buy Instead (StockStory)
Jul-23-25 10:20AM	Lucky Strike Entertainment (LUCK) Soars 9.2%: Is Further Upside Left in the Stock? (Zacks)
Jul-14-25 11:33PM	Winners And Losers Of Q1: Lucky Strike (NYSE:LUCK) Vs The Rest Of The Leisure Facilities Stocks (StockStory)
Jul-10-25 04:15PM	Lucky Strike Entertainment Unlocks Long-Term Value with $306 Million Acquisition of Real Estate at 58 Existing Locations (Business Wire)
Jul-07-25 10:11AM	The Top 5 Analyst Questions From Lucky Strike's Q1 Earnings Call (StockStory)
Jul-02-25 10:55AM	Rolling up with Lucky Strike (GuruFocus.com)
Jun-25-25 06:18PM	Lucky Strike Entertainment Corporation (LUCK): A Bear Case Theory (Insider Monkey)
Jun-23-25 08:00AM	Lucky Strike Entertainment Appoints Industry Leaders Richard Born and Jason Harinstein to Board of Directors (Business Wire)
Jun-17-25 07:58AM	52-Week Lows? No Problem for 3 Stocks With Big Upside Potential (MarketBeat)
Jun-16-25 04:30PM	Lucky Strike Entertainment's 2025 Summer Season Pass Soars Past 200,000 Members and over $10.3 Million! (Business Wire)
May-27-25 12:37AM	3 Volatile Stocks with Mounting Challenges (StockStory)
May-13-25 08:00AM	Lucky Strike Entertainment Launches 2025 Summer Season Pass (Business Wire)
May-10-25 11:00AM	Lucky Strike price target lowered to $13 from $16 at Stifel (TipRanks)
May-09-25 03:26AM	Lucky Strike Entertainment Corp (LUCK) Q3 2025 Earnings Call Highlights: Navigating Growth ... (GuruFocus.com) +5.54%
12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-08-25 08:55AM	Lucky Strike Entertainment (LUCK) Misses Q3 Earnings and Revenue Estimates (Zacks) -13.17%
07:30AM	Lucky Strike Entertainment Reports Third Quarter Results for Fiscal Year 2025 (Business Wire)
May-07-25 06:35PM	Inspirato Incorporated (ISPO) Q1 Earnings Beat Estimates (Zacks)
10:13AM	Lucky Strike Entertainment Corp (LUCK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-01-25 10:01AM	Lucky Strike Entertainment (LUCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-29-25 05:01AM	Spotting Winners: AMC Entertainment (NYSE:AMC) And Leisure Facilities Stocks In Q4 (StockStory)
Apr-28-25 08:00AM	O'Keefe Stevens Advisory Q1 2025 Investor Letter (Seeking Alpha)
05:01AM	Q4 Rundown: Life Time (NYSE:LTH) Vs Other Leisure Facilities Stocks (StockStory)
Apr-24-25 04:15PM	Lucky Strike Entertainment to Report Third Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Apr-15-25 09:53AM	Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Surges 7.3%: Is This an Indication of Further Gains? (Zacks)
Apr-08-25 05:08AM	3 Reasons LUCK is Risky and 1 Stock to Buy Instead (StockStory)
Apr-07-25 11:19AM	Lucky Strike Entertainment Stock Dips 19% in 3 Months: How to Play It? (Zacks)
Mar-07-25 08:30AM	Lucky Strike Entertainment Launches Rebrand Initiative, Bringing Elevated Entertainment to More Cities Nationwide (Business Wire)
Mar-05-25 04:15PM	Lucky Strike Entertainment Continues Expansion with the Acquisition of Visalia Adventure Park in California (Business Wire)
Feb-20-25 04:05PM	Brett Parker Retires from Lucky Strike Entertainment after 24 Years of Service (Business Wire)
Feb-19-25 05:30AM	Bao Buns and Coat Checks Come to Lucky Strike Bowling Alleys (and Cost Cuts Too) (The Wall Street Journal)
Feb-05-25 07:30AM	Lucky Strike Entertainment Reports Second Quarter Results for Fiscal Year 2025 (Business Wire)
Jan-29-25 10:01AM	Lucky Strike Entertainment (LUCK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-22-25 04:15PM	Lucky Strike Entertainment to Report Second Quarter 2025 Financial Results on February 5, 2025 (Business Wire)
Jan-08-25 07:40AM	Lucky Strike price target lowered to $15 from $16 at Truist (TipRanks)
Dec-20-24 08:30AM	Lucky Strike Entertainment Opens a New Location in Ladera Ranch (Business Wire)
Dec-12-24 08:30AM	Bowlero Completes Rebrand to Lucky Strike Entertainment with NYSE Ticker LUCK (Business Wire)

Lucky Strike Entertainment Corp. engages in operating bowling centers. It offers entertainment concepts with lounge seating, arcades, food and beverage offerings, and hosting and overseeing professional and non-professional bowling tournaments and related broadcasting. The company was founded by Thomas F. Shannon in 1997 and is headquartered in Mechanicsville, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Harinstein Jason	Director	Feb 12 '26	Buy	7.54	13,000	98,020	13,000	Feb 13 07:41 AM
Young John Alan	Director	Feb 06 '26	Buy	6.50	6,000	39,000	85,518	Feb 10 10:07 AM
Lavan Robert M.	Chief Financial Officer	Dec 08 '25	Buy	8.53	243	2,073	80,661	Dec 09 04:36 PM
Bass Robert J	Director	Dec 08 '25	Buy	8.46	520	4,402	50,503	Dec 09 04:36 PM
Ekster Lev	President	Dec 08 '25	Buy	8.75	38	332	67,546	Dec 09 04:36 PM
Born Richard Meynard	Director	Nov 28 '25	Buy	8.09	30,000	242,736	30,000	Dec 02 06:12 PM
Born Richard Meynard	Director	Nov 28 '25	Buy	8.09	30,000	242,736	30,000	Dec 02 06:12 PM
Young John Alan	Director	Nov 17 '25	Buy	7.62	4,685	35,700	79,518	Nov 18 04:04 PM
Young John Alan	Director	Nov 07 '25	Buy	7.90	1,500	11,850	74,833	Nov 10 04:48 PM
Young John Alan	Director	Nov 06 '25	Buy	7.95	100	795	73,333	Nov 10 04:48 PM
Lavan Robert M.	Chief Financial Officer	Sep 12 '25	Buy	10.07	174	1,754	87,105	Sep 16 08:08 AM
Lavan Robert M.	Chief Financial Officer	Sep 05 '25	Buy	9.94	2,500	24,850	86,931	Sep 05 01:24 PM
Ekster Lev	President	Sep 05 '25	Buy	9.99	2,505	25,025	71,800	Sep 05 01:24 PM
Lavan Robert M.	Chief Financial Officer	Jun 06 '25	Buy	9.04	193	1,743	84,431	Jun 11 04:48 PM
Young John Alan	Director	Jun 02 '25	Buy	8.32	785	6,531	73,233	Jun 03 12:11 PM
Young John Alan	Director	May 28 '25	Buy	8.72	1,565	13,647	72,448	May 29 05:01 PM
Shannon Thomas F.	Chief Executive Officer	May 28 '25	Buy	8.73	20,000	174,600	2,364,000	May 29 10:08 AM
Ekster Lev	President	May 09 '25	Buy	8.24	3,034	25,000	69,295	May 12 09:52 AM
Lavan Robert M.	Chief Financial Officer	May 09 '25	Buy	8.30	4,000	33,200	84,238	May 12 09:52 AM
Shannon Thomas F.	Chief Executive Officer	May 09 '25	Buy	8.48	44,000	373,204	2,344,000	May 12 09:51 AM
Young John Alan	Director	Mar 07 '25	Buy	8.95	100	895	70,883	Mar 10 03:33 PM
Lavan Robert M.	Chief Financial Officer	Mar 07 '25	Buy	9.38	161	1,514	80,238	Mar 10 03:33 PM
Bass Robert J	Director	Mar 10 '25	Buy	9.80	167	1,636	49,983	Mar 10 03:33 PM
Young John Alan	Director	Mar 05 '25	Buy	9.85	1,050	10,342	70,473	Mar 07 11:07 AM
Young John Alan	Director	Mar 06 '25	Buy	9.50	310	2,945	70,783	Mar 07 11:07 AM
Young John Alan	Director	Feb 24 '25	Buy	10.13	3,685	37,329	69,423	Feb 24 06:08 PM
Young John Alan	Director	Feb 21 '25	Buy	10.50	1,000	10,500	65,738	Feb 24 06:08 PM
Parker Brett I.	Executive Vice Chairman	Feb 20 '25	Sale	11.54	1,747,434	20,165,388	498,092	Feb 21 06:51 PM

Open in Screener

ONCY

Oncolytics Biotech, Inc

Feb 13 • 10:54AM ET

0.8604

+0.0257 3.08 %

Healthcare • Biotechnology • Canada • NASD

ONCY Oncolytics Biotech, Inc daily Stock Chart

Peers: CRSP NTLA EDIT BLUE CLLS FATE IOVA ADAP PSTX TCRT

Index	-	P/E	-	EPS (ttm)	-0.28	Insider Own	1.86%	Shs Outstand	103.64M	Perf Week	-2.88%
Market Cap	92.59M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	24.14%	Shs Float	98.50M	Perf Month	-18.06%
Enterprise Value	84.31M	PEG	-	EPS next Q	-0.06	Inst Own	2.80%	Short Float	3.89%	Perf Quarter	-24.19%
Income	-25.30M	P/S	-	EPS this Y	9.24%	Inst Trans	2.10%	Short Ratio	3.58	Perf Half Y	-8.50%
Sales	0.00M	P/B	1075.50	EPS next Y	5.44%	ROA	-175.83%	Short Interest	3.83M	Perf YTD	-1.56%
Book/sh	0.00	P/C	10.43	EPS next 5Y	7.08%	ROE	-745.66%	52W High	1.51 -43.02%	Perf Year	11.44%
Cash/sh	0.08	P/FCF	-	EPS past 3/5Y	8.27% 23.13%	ROIC	-5239.11%	52W Low	0.33 164.09%	Perf 3Y	-47.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.92% 9.89%	Perf 5Y	-67.90%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-4.93%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-65.17%
Dividend Ex-Date	-	Quick Ratio	1.84	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.32	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	-13.66%	SMA20	-13.06%	Beta	0.99	Target Price	5.50
Payout	-	Debt/Eq	7.50	Sales Q/Q	-	SMA50	-12.07%	Rel Volume	4.46	Prev Close	0.83
Employees	28	LT Debt/Eq	5.00	Earnings	Nov 13 BMO	SMA200	-10.50%	Avg Volume	1.07M	Price	0.86
IPO	Oct 05, 2001	Option/Short	No / No	EPS/Sales Surpr.	-61.39% -	Trades		Volume	1,217,941	Change	3.08%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-25	Initiated	Lake Street	Buy	$7
Oct-06-22	Initiated	Maxim Group	Buy	$3
Feb-17-21	Initiated	H.C. Wainwright	Buy	$15

Feb-05-26 09:35AM	$207B Market Shift: The Race for Fast Track Approval in Oncology (PR Newswire) -7.04%
08:55AM	Oncolytics receives FDA Fast Track Designation for pelareorep (TipRanks)
Feb-04-26 08:50AM	Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer (GlobeNewswire)
Jan-30-26 10:36AM	$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium (PR Newswire)
10:19AM	$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors (PR Newswire)
09:15AM	Loading…
Jan-28-26 09:15AM	Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment (PR Newswire)
Jan-27-26 10:50AM	Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks (PR Newswire)
Jan-15-26 04:01PM	Oncolytics Biotech Announces Results of Special Meeting of Shareholders (GlobeNewswire) -7.33%
Jan-14-26 10:52AM	Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff (PR Newswire)
09:00AM	Oncolytics Biotech Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics (GlobeNewswire)
Jan-12-26 10:35AM	Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 (PR Newswire)
09:00AM	Oncolytics Biotech Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer (GlobeNewswire)
04:23AM	Oncolytics Biotech (ONCY) Leadership Strengthens As Pelareorep Advances (Insider Monkey)
Jan-10-26 09:05AM	Oncolytics outlines strategic rationale for proposal to change jurisdiction (TipRanks)
Jan-09-26 09:00AM	Oncolytics Biotech Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada (GlobeNewswire)
09:00AM	Loading…
Jan-08-26 09:00AM	Oncolytics Biotech Provides Update on Intellectual Property Strategy and Patent Filings (Business Wire)
Jan-07-26 10:32AM	How $594B in Precision Tech is Cracking the Metastatic Cancer Code (PR Newswire)
09:00AM	Oncolytics Biotech Expands Its Gastrointestinal Tumor Scientific Advisory Board with the Addition of Dr. Eileen OReilly, Dr. Neil Segal, and Dr. Van Morris (Business Wire)
Dec-31-25 07:25AM	Smart Oncology: 5 Stocks Chasing the $317B Prize (PR Newswire)
Dec-16-25 01:17PM	Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B (PR Newswire) +12.68%
09:00AM	Oncolytics Biotech Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer (Business Wire)
Dec-12-25 10:47AM	Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance (PR Newswire)
Dec-09-25 06:00PM	Oncolytics Biotech Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada (Business Wire)
Dec-03-25 09:35AM	Oncolytics Biotech (ONCY) Loses 8.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-20-25 04:05PM	Oncolytics Biotech Provides Update on Special Meeting of Shareholders (Business Wire)
Nov-19-25 12:00PM	All You Need to Know About Oncolytics Biotech (ONCY) Rating Upgrade to Buy (Zacks)
09:00AM	Oncolytics Biotech Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer (Business Wire)
Nov-04-25 08:00AM	Oncolytics Biotech Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy (Business Wire) -11.48%
Oct-28-25 07:30AM	Oncolytics Biotech Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care (PR Newswire)
Oct-20-25 09:00AM	Oncolytics Biotech Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada (PR Newswire)
08:30AM	Loading…
Sep-29-25 08:30AM	Oncolytics Biotech Announces Update for Potential First-Line Pancreatic Cancer Registration Study (PR Newswire) +9.30%
Sep-16-25 12:29PM	Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals (PR Newswire)
07:00AM	Oncolytics Biotech Provides Update on GOBLET Study Progress and U.S. Site Expansion (PR Newswire)
Sep-08-25 09:30AM	Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market (PR Newswire) +20.75%
07:00AM	Oncolytics Biotech Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions (PR Newswire)
Sep-02-25 09:30AM	Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands (PR Newswire) +10.58%
09:10AM	Oncolytics Biotech Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors (PR Newswire)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
Aug-28-25 10:44AM	FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone (PR Newswire)
08:30AM	Oncolytics Biotech Announces Upcoming Investor Conferences in September (PR Newswire)
Aug-14-25 12:30PM	Biotech Stocks Rally as Oncology Market Targets $866B by 2034 (PR Newswire) -7.81%
12:22PM	Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment (PR Newswire)
Aug-11-25 04:55PM	Oncolytics Biotech Announces Voting Results from the Annual General Meeting of Shareholders (PR Newswire)
Aug-08-25 09:05AM	Oncolytics Biotech Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep (PR Newswire) -6.20%
09:00AM	Oncolytics Biotech Announces Voluntary Delisting from the Toronto Stock Exchange (PR Newswire)
Aug-05-25 08:30AM	Oncolytics Biotech Announces Upcoming Annual General Meeting and Second Quarter Financial Results (PR Newswire) +7.58%
Jul-29-25 03:46PM	Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments (PR Newswire) -6.42%
08:30AM	Oncolytics Biotech to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End (PR Newswire)
Jul-23-25 09:39AM	Key Opinion Leader Event Highlights Pelareorep's Compelling Pancreatic and Gastrointestinal Data And Future Potential (PR Newswire)
09:26AM	High-Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds (PR Newswire)
Jul-22-25 03:32PM	Oncolytics Biotech Regains Compliance with Nasdaq Trading Rules (PR Newswire)
Jul-16-25 06:51PM	Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities (PR Newswire) +10.62% +5.60%
08:30AM	Oncolytics Biotech Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types (PR Newswire)
Jul-10-25 09:20AM	Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up (PR Newswire) -7.08%
08:30AM	Oncolytics Biotech to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers (PR Newswire)
Jul-08-25 08:30AM	Oncolytics Biotech Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies (PR Newswire) +23.76%
Jun-30-25 11:02AM	Oncology Innovation Just Hit a Turning Point -- Here's What to Watch (PR Newswire)
07:00AM	Oncolytics Biotech Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy (PR Newswire)
Jun-26-25 11:44AM	The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? (PR Newswire)
Jun-24-25 12:52PM	Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices (PR Newswire) +5.79%
Jun-20-25 09:21AM	With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology (PR Newswire) -6.74%
Jun-18-25 11:19AM	Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going (PR Newswire) +10.76%
Jun-12-25 10:00AM	As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry (PR Newswire)
09:00AM	After Major Oncology Conference, All Eyes Turn to Industry Innovation (PR Newswire)
Jun-11-25 07:00AM	Oncolytics Biotech Names New CEO to Accelerate Momentum in Immunotherapy Programs (PR Newswire) +34.10%
May-23-25 09:10AM	New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs (PR Newswire)
07:00AM	Oncolytics Biotech to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities (PR Newswire)
May-15-25 03:15AM	Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
May-14-25 04:01PM	Oncolytics Biotech Reports First Quarter Financial Results and Highlights Clinical Momentum (PR Newswire)
May-06-25 07:00AM	Oncolytics Biotech to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights (PR Newswire) -6.42%
May-01-25 11:04AM	New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty (PR Newswire)
Apr-24-25 07:00AM	Oncolytics Biotech to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action (PR Newswire)
Apr-14-25 10:15AM	With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz (PR Newswire) -5.28%
Apr-10-25 06:09PM	Oncolytics Biotech Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital (PR Newswire) +24.56%
07:00AM	Oncolytics Biotech and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers (PR Newswire)
Mar-08-25 07:33AM	Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge (PR Newswire)
02:03AM	Oncolytics Biotech Inc (ONCY) Q4 2024 Earnings Call Highlights: Promising Cancer Study Results ... (GuruFocus.com)
Mar-07-25 07:00AM	Oncolytics Biotech Reports Highlights and Financial Results for Q4 and Year-End 2024 (PR Newswire) -6.29%
Mar-05-25 09:35AM	Oncolytics Biotech (ONCY) Loses -9.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +13.52%
Feb-27-25 10:10AM	Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 (PR Newswire)
Feb-25-25 07:00AM	Oncolytics Biotech to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights (PR Newswire)
Feb-19-25 10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire)
07:00AM	Oncolytics Biotech Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025 (PR Newswire)
Feb-18-25 07:00AM	Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer (PR Newswire)
Feb-14-25 05:15PM	Oncolytics Biotech Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency (PR Newswire)
Feb-07-25 09:24PM	Oncolytics Biotech Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence (PR Newswire)
Feb-05-25 12:00PM	Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jan-22-25 09:00AM	Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium (PR Newswire) +5.26%
07:00AM	Oncolytics Biotech to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium (PR Newswire)
Jan-16-25 11:17AM	German PEI approves enrolment in cohort 5 of Oncolytics pancreatic cancer trial (Clinical Trials Arena)
Jan-15-25 10:10AM	Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year (PR Newswire)
07:02AM	Regulatory Approval Clears Path for Oncolytics Biotech to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data (PR Newswire)
Dec-26-24 11:26AM	Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment (PR Newswire)
09:00AM	Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook (GlobeNewswire)
Dec-23-24 10:49AM	How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options (PR Newswire) +9.00%
07:00AM	Oncolytics Biotech Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data (PR Newswire)
Dec-20-24 12:52PM	Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses (PR Newswire) -6.36%
Dec-18-24 11:12AM	Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments (PR Newswire)
08:45AM	Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic and Anal Cancers (GlobeNewswire)
07:00AM	Oncolytics Biotech to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium (PR Newswire)

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kelly Jared	Chief Executive Officer	Feb 12 '26	Buy	0.84	29,500	24,839	109,000	Feb 13 07:00 AM
Kelly Jared	Chief Executive Officer	Feb 11 '26	Buy	0.84	5,600	4,682	79,500	Feb 13 07:00 AM
Look Kirk	Chief Financial Officer	Feb 12 '26	Buy	0.84	12,000	10,104	287,515	Feb 13 07:00 AM
Pisano Wayne	Director	Feb 12 '26	Buy	0.84	30,000	25,338	492,414	Feb 13 07:00 AM
Heineman Thomas Charles	Chief Medical Officer	Feb 12 '26	Buy	0.83	12,132	10,033	282,818	Feb 13 07:00 AM
Brown Deborah Margaret	Director	Feb 12 '26	Buy	0.85	25,000	21,240	109,851	Feb 13 07:00 AM
Hagerman Allison	VP, Product Development	Feb 12 '26	Buy	0.83	10,000	8,298	115,059	Feb 13 07:00 AM
Seizinger Bernd R.	Director	Feb 11 '26	Buy	0.83	60,000	49,590	526,991	Feb 13 07:00 AM
Seizinger Bernd R.	Director	Feb 12 '26	Buy	0.85	40,000	33,864	566,991	Feb 13 07:00 AM
Aromando Andrew	Chief Business Officer	Feb 11 '26	Buy	0.86	29,600	25,418	55,100	Feb 13 07:00 AM
Andrews Patricia S	Director	Feb 12 '26	Buy	0.86	35,400	30,292	78,128	Feb 13 07:00 AM
Seizinger Bernd R.	Director	Jan 16 '26	Buy	1.04	100,000	103,770	466,991	Jan 20 04:30 PM

PSEC

Prospect Capital Corp

LUCK

Lucky Strike Entertainment Corp

ONCY

Oncolytics Biotech, Inc

Upgrade your FINVIZ experience